Donald James Scotti
Nessuna posizione attualmente
Profilo
Donald James Scotti formerly worked at Sweet Spot Productions, Inc., as President & Chief Executive Officer in 2010, Sycamore Entertainment Group, Inc., as President & Director, ImaRx Therapeutics, Inc., as President in 2010, Kaleidoscope Films Group LLC, as Vice President & Producer in 2005, and After Dark Films, as Executive Vice President.
Precedenti posizioni note di Donald James Scotti
| Società | Posizione | Fine |
|---|---|---|
ImaRx Therapeutics, Inc.
 ImaRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImaRx Therapeutics, Inc. manufactures biopharmaceutical products. The company develops and manufactures therapies for vascular disorders associated with blood clots based on two programs, thrombolytics and sonoLysis. Its therapeutics products are approved by the US Food, Drug Administration and FDA, for the treatment of acute pulmonary embolism or blood clots in the lungs. The company was founded in 1991 and is headquartered in Los Angeles, CA | Presidente | 29/11/2010 |
| Sweet Spot Productions, Inc. | Presidente | 01/01/2010 |
| Kaleidoscope Films Group LLC | Corporate Officer/Principal | 01/01/2005 |
| After Dark Films | Corporate Officer/Principal | - |
| SYCAMORE ENTERTAINMENT GROUP, INC. | Presidente | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SYCAMORE ENTERTAINMENT GROUP, INC. | Consumer Services |
| Aziende private | 4 |
|---|---|
ImaRx Therapeutics, Inc.
ImaRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImaRx Therapeutics, Inc. manufactures biopharmaceutical products. The company develops and manufactures therapies for vascular disorders associated with blood clots based on two programs, thrombolytics and sonoLysis. Its therapeutics products are approved by the US Food, Drug Administration and FDA, for the treatment of acute pulmonary embolism or blood clots in the lungs. The company was founded in 1991 and is headquartered in Los Angeles, CA | Health Technology |
| Sweet Spot Productions, Inc. | |
| Kaleidoscope Films Group LLC | |
| After Dark Films |
- Borsa valori
- Insiders
- Donald James Scotti
